ELEV
Elevation Oncology
ELEV
ELEV
Delisted
ELEV was delisted on the 22nd of July, 2025.
27 hedge funds and large institutions have $21.5M invested in Elevation Oncology in 2022 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 5 reducing their positions, and 6 closing their positions.
Holders
27
Holders Change
-4
Holders Change %
-12.9%
% of All Funds
0.46%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
2
Increased
9
Reduced
5
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
DCM
26
Driehaus Capital Management
Chicago,
Illinois
| – | – | -1,571,509 | Closed |
|
|
VC
27
Vivo Capital
Palo Alto,
California
| – | – | -496,844 | Closed |
|
|
B
28
Bailard
Foster City,
California
| – | – | -23,500 | Closed |
|
|
LCM
29
Lynx1 Capital Management
San Juan,
Puerto Rico
| – | – | -10,000 | Closed |
|
30
Morgan Stanley
New York
| $0 | 115 | -6,224 | -98% |
|
31
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | – | -60 | Closed |
|
32
Bank of America
Charlotte,
North Carolina
| – | – | -1 | Closed |
|
|
CFGS
33
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|
34
Wells Fargo
San Francisco,
California
| $0 | 42 | +3 | +8% |
|